enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Physicians' Desk Reference - Wikipedia

   en.wikipedia.org/wiki/Physicians'_Desk_Reference

   The Physicians' Desk Reference (PDR), renamed Prescriber's Digital Reference after its physical publication was discontinued, is a compilation of manufacturers' prescribing information (package insert) on prescription drugs, updated regularly and published by ConnectiveRx.

3. Consumer Reports - Wikipedia

   en.wikipedia.org/wiki/Consumer_Reports

   Consumer Reports (CR), formerly Consumers Union (CU), is an American nonprofit consumer organization dedicated to independent product testing, investigative journalism, consumer-oriented research, public education, and consumer advocacy.

4. Adverse effect - Wikipedia

   en.wikipedia.org/wiki/Adverse_effect

   Adverse effects, like therapeutic effects of drugs, are a function of dosage or drug levels at the target organs, so they may be avoided or decreased by means of careful and precise pharmacokinetics, the change of drug levels in the organism in function of time after administration. Adverse effects may also be caused by drug interaction. This ...

5. Finkelstein Thompson LLP Announces Investigation of ... - AOL

   www.aol.com/2012/10/01/finkelstein-thompson-llp...

   For premium support please call: 800-290-4726 more ways to reach us

6. Proportional reporting ratio - Wikipedia

   en.wikipedia.org/wiki/Proportional_reporting_ratio

   Thus, nausea was reported with proportion 1489 / 53789 = 0.028 for the class of drugs. The PRR in this case is 0.061 / 0.028 = 2.18. This tells us that nausea was reported more than twice as frequently (among all adverse event reports) for the drug of interest compared to drugs in the comparison group.

7. Centrum (multivitamin) - Wikipedia

   en.wikipedia.org/wiki/Centrum_(multivitamin)

   No statistically significant effects were found for any specific cancers or cancer mortality. The 95% CI of the hazard ratio implied a benefit of between 14% and .2% over placebo. In absolute terms the difference was 1.3 cancer diagnoses, per 1000 years of life (18.3-17 events, respectively). The median follow up time was 11.2 years. [3]